Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cotler

Showing results (261-270 of 339) with videos related to

Pageof 34
Sort By:
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 13, 2002
Induction of IL-1Ra in resistant and responsive hepatitis C patients following treatment with IFN-con1Scott J Cotler, Teresa Craft, Mary Ferris, et al.
Brain : a Journal of Neurology|September 6, 2024
Intracerebral delivery of antiseizure medications by microinvasive neural implantsHannah D Jackson, Max J Cotler, Gerald W Saunders, et al.
Transplantation|September 19, 2007
Diabetes and hepatic oxidative damage are associated with hepatitis C progression after liver transplantationScott J Cotler, Eric Kallwitz, Veronica TenCate, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|September 14, 2021
FIGO staging for carcinoma of the vulva: 2021 revisionAlexander B Olawaiye, Joseph Cotler, Mauricio A Cuello, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2013
Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-lifeJeremie Guedj, Harel Dahari, Libin Rong, et al.
Science (New York, N.Y.)|June 9, 2022
Quantum advantage in learning from experimentsHsin-Yuan Huang, Michael Broughton, Jordan Cotler, et al.
Spine|December 17, 1997
Neurologic outcome of early versus late surgery for cervical spinal cord injuryA R Vaccaro, R J Daugherty, T P Sheehan, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2018
Focal, remote-controlled, chronic chemical modulation of brain microstructuresKhalil B Ramadi, Canan Dagdeviren, Kevin C Spencer, et al.
Virology Journal|May 5, 2009
Ethnic and geographical differences in HLA associations with the outcome of hepatitis C virus infectionJane H Wang, Xin Zheng, Xiaogang Ke, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 25, 2014
Sustained virological response with intravenous silibinin: individualized IFN-free therapy via real-time modelling of HCV kineticsHarel Dahari, Shimon Shteingart, Inna Gafanovich, et al.
Pageof 34

Showing results (261-270 of 339) with videos related to

Sort By:
Pageof 34
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 13, 2002
Induction of IL-1Ra in resistant and responsive hepatitis C patients following treatment with IFN-con1Scott J Cotler, Teresa Craft, Mary Ferris, et al.
Brain : a Journal of Neurology|September 6, 2024
Intracerebral delivery of antiseizure medications by microinvasive neural implantsHannah D Jackson, Max J Cotler, Gerald W Saunders, et al.
Transplantation|September 19, 2007
Diabetes and hepatic oxidative damage are associated with hepatitis C progression after liver transplantationScott J Cotler, Eric Kallwitz, Veronica TenCate, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|September 14, 2021
FIGO staging for carcinoma of the vulva: 2021 revisionAlexander B Olawaiye, Joseph Cotler, Mauricio A Cuello, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2013
Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-lifeJeremie Guedj, Harel Dahari, Libin Rong, et al.
Science (New York, N.Y.)|June 9, 2022
Quantum advantage in learning from experimentsHsin-Yuan Huang, Michael Broughton, Jordan Cotler, et al.
Spine|December 17, 1997
Neurologic outcome of early versus late surgery for cervical spinal cord injuryA R Vaccaro, R J Daugherty, T P Sheehan, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2018
Focal, remote-controlled, chronic chemical modulation of brain microstructuresKhalil B Ramadi, Canan Dagdeviren, Kevin C Spencer, et al.
Virology Journal|May 5, 2009
Ethnic and geographical differences in HLA associations with the outcome of hepatitis C virus infectionJane H Wang, Xin Zheng, Xiaogang Ke, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 25, 2014
Sustained virological response with intravenous silibinin: individualized IFN-free therapy via real-time modelling of HCV kineticsHarel Dahari, Shimon Shteingart, Inna Gafanovich, et al.
Pageof 34